AIS Biotech
AIS Biotech
Description
AIS Biotech (where AIS stands for Anti Infective Sugar) is a French biotech company created in March 2023, intending to develop a new class of sugar-based anti-infective biotherapeutics. They act as decoy receptors that prevent the attachment of pathogens to epithelial cell surface sugars.
AIS Biotech
Address
22 rue Saint Ferjus 38000 GRENOBLE
Grenoble, France
Grenoble, France
Contact
contact@ais-biotech.com
Description
AIS Biotech (where AIS stands for Anti Infective Sugar) is a French biotech company created in March 2023, intending to develop a new class of sugar-based anti-infective biotherapeutics. They act as decoy receptors that prevent the attachment of pathogens to epithelial cell surface sugars.
Matchmaking
Connect with AIS Biotech
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways